Sign in

NCT06675279Completed

Psychometric Properties of the Turkish Version of the HANA in Migraine

The Headache Needs Assessment (HANA) Survey: Psychometric Properties of the Turkish Version in Migraine

Source: ClinicalTrials.gov · Last updated 5 Nov 2024

Brief summary (registry, in English)

Migraine is one of the most common neurological disorders, affecting numerous adults. Headaches are often associated with significant disruptions that can interrupt the patient's usual activities for hours. Although headaches are typically episodic, many individuals with migraine experience life restrictions due to the anticipation of future attacks and the prevalent concern that headaches will compromise their functional capabilities. Several health-related quality of life scales have been developed to assess migraine and its associated conditions. Some examples include the Migraine-Specific Quality of Life Questionnaire, the Quality of Life and Migraine Scale, and the Migraine-Specific Quality of Life Measure. While some of these scales have Turkish versions, others do not. Many of these instruments are designed for clinical research, offering comprehensive assessment but are disadvantaged by lengthy completion and scoring times for patients. There is a need for brief health status measures with simple scoring systems that can evaluate the overall impact of migraines on daily activities. The Headache Needs Assessment (HANA) is a seven-item questionnaire developed to assess migraine-related quality of life issues. This study aims to validate and establish the reliability of the Turkish version of the Headache Needs Assessment for evaluating individuals with migraines. If proven valid and reliable, the Headache Needs Assessment will be a practical tool for assessing the quality of life in individuals with migraines. Null Hypothesis (H0): The Turkish version of the Headache Needs Assessment is not valid and reliable. Alternative Hypothesis (H1): The Turkish version of the Headache Needs Assessment is valid and reliable.

Status (registry)
Completed
Study type
Observational
Enrollment
79 (actual)
First submitted
2 Nov 2024
Start date
1 Mar 2024
Primary completion date
1 Sept 2024
Lead sponsor
Tokat Gaziosmanpasa University
Diseases
Migraine
NCT number
NCT06675279

What you commit to

  • Study type: Observational
  • Participants enrolled: 79
  • From 1 Mar 2024 to the primary completion date, 1 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Having a diagnosis of any headache disorder other than chronic migraine,
  • Having a history of any systemic disease, such as malignancy, inflammatory conditions, acute fractures, surgical history, neurological, psychological, or rheumatological disorders.

Who the study is looking for

  • Having a diagnosis of chronic migraine (headaches occurring on more than 15 days per month for over three months, with migraine headaches on at least eight days per month),
  • Being between 18 and 65 years of age,
  • Experiencing neck pain during migraine attacks.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Tokat Gaziosmanpaşa University
Coordinator of this site? Confirm its status
Tokat ProvinceTurkey (Türkiye)Unknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.